Search Browse Earnings

ImageneBio, Inc. — SlamSEC

ImageneBio, Inc.

Nasdaq:IMA

Biological Products, (No Diagnostic Substances)·SAN DIEGO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$3.5M

-61.8% YoY

FY 2025

Adj. EBITDA

-$35.9M

-1025.7% margin

FY 2025

Net Income

-$36.6M

-1044.8% margin

FY 2025

EPS (Diluted)

-$22.10

FY 2025

Stock Price

$6.07

+2.2%

2026-03-10

52W Range

$5.70 – $18.00

P/E Ratio

-0.3x

Market Cap

$67.9M

Cash

$12.1M

FY 2025

Total Debt

$7.5M

FY 2025

Net Cash

$4.6M

FY 2025

Enterprise Value

$63.3M

Debt / EBITDA

0.1x

FY 2025

EV / EBITDA

-1.8x

Employees

—